Bioterrorism Assay Expedited Review Backed By House Med Tech Caucus
This article was originally published in The Gray Sheet
Executive Summary
Roche will submit an investigational device exemption to FDA the week of Nov. 19 for a one-hour anthrax assay developed in collaboration with the Mayo Clinic